BIOSU — BioPlus Acquisition Share News
0.000.00%
FinancialsAdventurousSmall Cap
- $271.27m
- $276.52m
Brief: Bioplus Acquisition Corp. Announces Termination Of Business Combination Agreement With Avertix Medical
Brief: Avertix To Become Publicly Traded Via Merger With Bios Acquisition Corp
Brief: BioPlus Acquisition Says Ceased Use Of Its Name In Marketing & Public Materials, Other Than When Use Of Co's Legal Name Is Needed In Certain Documents
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
Brief: Bioplus Acquisition Corp. Announces Pricing Of Upsized $200,000,000 Initial Public Offering
Brief: Blank Check Co, Bioplus Acquisition Corp Files To Cut The Size Of IPO To Up To $180 Million From Up To $220 Million - SEC Filing